
    
      This study will assess the safety and efficacy of TG-873870 (Nemonoxacin) in patients with
      Diabetic Foot Infections. Pharmacokinetic (PK) and pharmacodynamic (PD) assessment will be
      conducted in a subgroup of eight consenting patients.
    
  